Johnson & Johnson JNJ.VI Stock
Johnson & Johnson Price Chart
Johnson & Johnson JNJ.VI Financial and Trading Overview
Johnson & Johnson stock price | 135.94 EUR |
Previous Close | 142.3 EUR |
Open | 143 EUR |
Bid | 0 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 141.9 - 143 EUR |
52 Week Range | 136 - 170.2 EUR |
Volume | 59 EUR |
Avg. Volume | 18 EUR |
Market Cap | 341.59B EUR |
Beta (5Y Monthly) | 0.573 |
PE Ratio (TTM) | 28.959183 |
EPS (TTM) | 6.27 EUR |
Forward Dividend & Yield | 4.39 (3.10%) |
Ex-Dividend Date | November 20, 2023 |
1y Target Est | N/A |
JNJ.VI Valuation Measures
Enterprise Value | 349.26B EUR |
Trailing P/E | 28.959183 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.4624658 |
Price/Book (mrq) | 4.795539 |
Enterprise Value/Revenue | 3.54 |
Enterprise Value/EBITDA | 9.975 |
Trading Information
Johnson & Johnson Stock Price History
Beta (5Y Monthly) | 0.573 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 170.2 EUR |
52 Week Low | 136 EUR |
50-Day Moving Average | 142.2 EUR |
200-Day Moving Average | 147.24 EUR |
JNJ.VI Share Statistics
Avg. Volume (3 month) | 18 EUR |
Avg. Daily Volume (10-Days) | 32 EUR |
Shares Outstanding | 2.41B |
Float | 2.4B |
Short Ratio | N/A |
% Held by Insiders | 0.093% |
% Held by Institutions | 71.12% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 4.64 |
Trailing Annual Dividend Yield | 3.26% |
5 Year Average Dividend Yield | 263.00% |
Payout Ratio | 0.8705 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | October 1, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | 35.09% |
Operating Margin (ttm) | 30.07% |
Gross Margin | 67.55% |
EBITDA Margin | 35.49% |
Management Effectiveness
Return on Assets (ttm) | 10.11% |
Return on Equity (ttm) | 19.18% |
Income Statement
Revenue (ttm) | 98.66B EUR |
Revenue Per Share (ttm) | 38.16 EUR |
Quarterly Revenue Growth (yoy) | 6.80% |
Gross Profit (ttm) | 63.95B EUR |
EBITDA | 35.01B EUR |
Net Income Avi to Common (ttm) | 13.99B EUR |
Diluted EPS (ttm) | 4.9 |
Quarterly Earnings Growth (yoy) | 483.80% |
Balance Sheet
Total Cash (mrq) | 23.51B EUR |
Total Cash Per Share (mrq) | 9.77 EUR |
Total Debt (mrq) | 29.92B EUR |
Total Debt/Equity (mrq) | 42.01 EUR |
Current Ratio (mrq) | 1.21 |
Book Value Per Share (mrq) | 29.59 |
Cash Flow Statement
Operating Cash Flow (ttm) | 20.28B EUR |
Levered Free Cash Flow (ttm) | 21.17B EUR |
Profile of Johnson & Johnson
Country | Austria |
State | NJ |
City | New Brunswick |
Address | One Johnson & Johnson Plaza |
ZIP | 08933 |
Phone | 732 524 0400 |
Website | https://www.jnj.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 152700 |
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Q&A For Johnson & Johnson Stock
What is a current JNJ.VI stock price?
Johnson & Johnson JNJ.VI stock price today per share is 135.94 EUR.
How to purchase Johnson & Johnson stock?
You can buy JNJ.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Johnson & Johnson?
The stock symbol or ticker of Johnson & Johnson is JNJ.VI.
Which industry does the Johnson & Johnson company belong to?
The Johnson & Johnson industry is Drug Manufacturers-General.
How many shares does Johnson & Johnson have in circulation?
The max supply of Johnson & Johnson shares is 2.41B.
What is Johnson & Johnson Price to Earnings Ratio (PE Ratio)?
Johnson & Johnson PE Ratio is 21.68102000 now.
What was Johnson & Johnson earnings per share over the trailing 12 months (TTM)?
Johnson & Johnson EPS is 6.27 EUR over the trailing 12 months.
Which sector does the Johnson & Johnson company belong to?
The Johnson & Johnson sector is Healthcare.